Croivalve

2 known investors

CroíValve develops the DUO System, a minimally invasive heart valve device designed to treat tricuspid regurgitation, a common and often underdiagnosed heart condition. The company targets patients suffering from this disease across the US and Europe.

HealthtechMedical Devices